1.37

6.16% -0.09

After Hours: 1.35 -0.02 -1.46%

Dermata Therapeutics Inc (DRMA)

Overview News Price History Financials Discussions Forecast Stock Split

Dermata Therapeutics Inc stock is traded at $1.37, with a volume of 178.96K. It is down -6.16% in the last 24 hours and up +9.60% over the past month. Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology for patients suffering with acne. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin.

Previous Close:

$1.46

Open:

$1.46

24h Volume:

178.96K

Relative Volume:

0.07

Market Cap:

$3.88M

Revenue:

Net Income/Loss:

$-8.85M

P/E Ratio:

-0.0842

EPS:

-16.2673

Net Cash Flow:

$-9.34M

1W Performance:

+13.22%

1M Performance:

+9.60%

6M Performance:

-73.60%

1Y Performance:

-89.85%

1-Day Range:

$1.36

$1.4699

1-Week Range:

$1.31

$1.84

52-Week Range:

$1.11

$23.70

Dermata Therapeutics Inc Stock (DRMA) Company Profile

Name

Dermata Therapeutics Inc

Sector

Healthcare (1113)

Industry

Biotechnology (623)

Phone

(858)-223-0882

Address

3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO

Employee

Twitter

Next Earnings Date

2026-03-30

Latest SEC Filings

DRMA's Discussions on Twitter

Compare DRMA vs VRTX, REGN, ALNY, ARGX, INSM

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DRMA Dermata Therapeutics Inc	1.37	4.14M	0	-8.85M	-9.34M	-16.27
VRTX Vertex Pharmaceuticals Inc	453.74	115.58B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	756.73	79.23B	14.34B	4.50B	3.77B	41.56
ALNY Alnylam Pharmaceuticals Inc	328.16	43.59B	3.71B	313.75M	465.38M	2.2571
ARGX Argen X Se Adr	692.83	43.26B	4.16B	1.29B	734.26M	19.58
INSM Insmed Inc	147.60	31.97B	606.42M	-1.28B	-997.58M	-6.403

Dermata Therapeutics Inc Stock (DRMA) Latest News

05:25 AM

Dermata Therapeutics 10-K: $7.56M net loss, operating expenses $7.77M - TradingView

05:25 AM

05:17 AM

Dermata Therapeutics (NASDAQ: DRMA) pivots from Rx acne to Tome OTC skincare - Stock Titan

05:17 AM

05:16 AM

Dermata (NASDAQ: DRMA) shifts to DTC skincare as 2025 loss shrinks - Stock Titan

05:16 AM

05:15 AM

From prescription acne to at-home skincare: Dermata targets 2026 launch - Stock Titan

05:15 AM

Mar 25, 2026

Analyst Downgrade: Will Dermata Therapeutics Inc benefit from AI trendsLong Setup & Precise Swing Trade Alerts - baoquankhu1.vn

Mar 25, 2026

Mar 24, 2026

Risk Recap: Is Dermata Therapeutics Inc Equity Warrant a strong candidate for buy and hold2026 Top Decliners & Comprehensive Market Scan Reports - baoquankhu1.vn

Mar 24, 2026

Mar 23, 2026

If You Invested $1,000 in Protagenic Therapeutics Inc (PTIX) - Stock Titan

Mar 23, 2026

If You Invested $1,000 in THERIVA BIOLOGICS INC (TOVX) - Stock Titan

Mar 23, 2026

Mar 22, 2026

Valuation Update: Is Dermata Therapeutics Inc. Equity Warrant stock risky to hold now2026 Summary & Safe Entry Point Identification - baoquankhu1.vn

Mar 22, 2026

Dermata Therapeutics Poised for Expansion with Strategic Skincare Launch - timothysykes.com

Mar 22, 2026

Mar 21, 2026

Dermata Therapeutics Strategically Pivots with New Skincare Launch - StocksToTrade

Mar 21, 2026

Dermata Therapeutics Strategically Expands into Skincare with Executive Appointment - timothysykes.com

Mar 21, 2026

Why Planet Labs Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket - Sahm

Mar 21, 2026

Mar 20, 2026

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Mar 20, 2026

Let's uncover which stocks are experiencing notable gaps during today's session. - ChartMill

Mar 20, 2026

Dermata Therapeutics Ramps Up Skincare Division with New VP Appointment - StocksToTrade

Mar 20, 2026

Dermata’s Strategic Pivot: New Skincare Line on the Horizon - timothysykes.com

Mar 20, 2026

Stay updated with the stocks that are on the move in today's pre-market session. - ChartMill

Mar 20, 2026

Dermata Gears Up For First Once-Weekly Acne Kit Launch, Eyeing A Slice Of $3.8B Market - RTTNews

Mar 20, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Mar 20, 2026

Mar 19, 2026

Get insights into the top gainers and losers of Thursday's after-hours session. - ChartMill

Mar 19, 2026

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Mar 19, 2026

Published on: 2026-03-20 05:04:24 - baoquankhu1.vn

Mar 19, 2026

DRMA Earnings History & Surprises | EPS & Revenue Results | DERMATA THERAPEUTICS INC (NASDAQ:DRMA) - ChartMill

Mar 19, 2026

Mar 18, 2026

Dermata Therapeutics (DRMAW) Expected to Announce Earnings on Wednesday - Defense World

Mar 18, 2026

Mar 17, 2026

Dermata Therapeutics (DRMA) SVP adds 1,000 shares in insider buy - Stock Titan

Mar 17, 2026

CEO Change: Whats the outlook for Dermata Therapeutics Incs sectorQuarterly Profit Summary & Weekly Watchlist for Consistent Profits - baoquankhu1.vn

Mar 17, 2026

Mar 13, 2026